New progression of lobaplatin in the treatment of gynecologic cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 848-851, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-466582
ABSTRACT
Lobaplatin is the third generation platinum anticancer drug,and has been listed for the clinical treatment of advanced breast cancer,small cell lung cancer and chronic myeloid leukemia.Studies have shown that lobaplatin as the latest third generation platinum anticancer drug,has good water solubility,broadspectrum anti-tumor,strong anti-tumor activity,no cross-resistance with other platinum drugs,low toxicity and many other features.Lobaplatin has shown a clear advantage.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS